ImmuCell Corporation
NASDAQ:ICCC
Overview | Financials
Company Name | ImmuCell Corporation |
Symbol | ICCC |
Currency | USD |
Price | 3.53 |
Market Cap | 27,650,772 |
Dividend Yield | 0% |
52-week-range | 3.34 - 5.59 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Michael F. Brigham |
Website | https://immucell.com |
An error occurred while fetching data.
About ImmuCell Corporation
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD